Resources
Filter by Topic
- Blogs
By Samy Suissa, PhD, Distinguished James McGill Professor of Epidemiology, Biostatistics, and Medicine, McGill University
- Press Releases
Panalgo, a Norstella company dedicated to revolutionizing healthcare data analytics, is announcing a new venture with partner OM1, a forefront leader in real-world evidence (RWE)...
- Press Releases
Norstella, one of the largest global pharma intelligence solution providers, today announced a strategic partnership with Atropos Health, the pioneer in translating real-world clinical data...
- Blogs
By Peter Neumann Director, Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center;...
- Blogs
By Meg Richards, PhD, MPH, Executive Director of Solutions, Panalgo
- Articles
By Meg Richards, PhD, MPH, Executive Director, Scientific Strategy at Panalgo, with Andrew Goldstein, VP of Client Partnerships at Panalgo
- Blogs
Three Key Themes from Panalgo’s Data to Insights 2024 Conference
Panalgo Brings the Power of Machine-Learning to the Healthcare Industry Via Its Instant Health Data (IHD) Software
BOSTON, Mass. – September 15, 2020 – Panalgo, a leading healthcare analytics company, today announced the launch of its new Data Science module for Instant Health Data
Panalgo to Present at ICPE 2020
The 2020 virtual International Conference for Pharmacoepidemiology (ICPE) takes place September 16-17. Panalgo will be sharing the following research during the virtual event, please join
5 Steps To Prepare For A Third-Party Drug Price Evaluation
In this Life Science Leader article, Matt Sussman discusses important steps to take when preparing for a third party drug price evaluation. Sussman notes that
Do Research Groups Align on an Intervention’s Value? Concordance of Cost-Effectiveness Findings Between the Institute for Clinical and Economic Review and Other Health System Stakeholders
Authors: Matthew Sussman, Jeffrey C Yu, Joseph Menzin Published: Applied Health Economics Health Policy Click here to view the article.
BHE is Now Panalgo: Why We Changed Our Name and Brand
In 1996, I started Boston Health Economics (BHE) to provide professional research services to the life sciences industry, including economic modeling, database analyses and strategic
BHE Announces Rebrand to Panalgo, Continues Its Mission of Leadership in Analytics Software for Healthcare [Press Release]
BOSTON, Mass. – July 27, 2020 – BHE, a leading healthcare analytics company, is now Panalgo. The new name reflects the company’s commitment to expanding the accessibility
IHD Analytics
Put reliable, rapid analytics in the hands of more people across your organization